several < severe < severity

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by severe

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000053 (2020)	Mazen Kreidy [États-Unis] ; Ali Al-Hilli [États-Unis] ; Ralph Yachoui [États-Unis] ; Jeffrey Resnick [États-Unis]	Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
000130 (2020)	Xueting Yao [République populaire de Chine] ; Fei Ye [République populaire de Chine] ; Miao Zhang [République populaire de Chine] ; Cheng Cui [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Xu Liu [République populaire de Chine] ; Li Zhao [République populaire de Chine] ; Erdan Dong [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Siyan Zhan [République populaire de Chine] ; Roujian Lu [République populaire de Chine] ; Haiyan Li [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Dongyang Liu [République populaire de Chine]	In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
000433 (2019)	Amy A. Yau ; Samira S. Farouk	Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient
000434 (2019)	Aprajita Jagpal ; Gagandeep Choudhary ; Jad Chokr [Liban]	Severe arthritis and tenosynovitis caused by immune checkpoint blockade therapy with pembrolizumab (anti-PD-1 antibody)
000524 (2019)	Sophia Grimes ; Kira Bombay ; Andrea Lanes ; Mark Walker ; Daniel J. Corsi	Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis
000851 (2019)	Sébastien Sanges ; Laurent Savale ; Nicolas Lamblin ; Martine Rémy-Jardin ; Marc Humbert ; Vincent Sobanski	Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
000975 (2019)	Beatriz Tejera Segura [Royaume-Uni] ; I Igo Rua-Figueroa [Espagne] ; Jose Maria Pego-Reigosa [Espagne] ; Victor Del Campo [Espagne] ; Chris Wincup [Royaume-Uni] ; David Isenberg [Royaume-Uni] ; Anisur Rahman [Royaume-Uni]	Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort
000B50 (2019)	Bicky Thapa [États-Unis] ; Asad Ali [États-Unis] ; Raunak Nair [États-Unis] ; Rishik Vashisht [États-Unis] ; Cassandra Calabrese [États-Unis]	A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
000C06 (2018)	P. El Boustany [France] ; R. Epaud [France] ; C. Grosse [France] ; F. Barriere [France] ; E. Grimont-Rolland [France] ; A. Carsin [France] ; J C Dubus [France]	Unusual long survival despite severe lung disease of a child with biallelic loss of function mutations in ABCA-3.
000C56 (2018)	Weihong Shi ; Mingyang Duan [République populaire de Chine] ; Ligang Jie ; Weifeng Sun	A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
000C83 (2017)	Sofia Silvério Serra ; Teresa Pedrosa ; Sandra Falcão ; Jaime Cunha Branco	[Severe Interstitial Lung Disease and Manic Symptoms Secondary to Corticosteroids in a Patient with Systemic Lupus Erythematosus and Secondary Sjögren's Syndrome].
000E29 (2016)	G. Ban [Corée du Sud] ; D. L. Pham [Corée du Sud] ; T. H. K. Trinh [Corée du Sud] ; S. Lee [Corée du Sud] ; D. Suh [Corée du Sud] ; E. Yang [Corée du Sud] ; Y. Ye [Corée du Sud] ; Y. S. Shin [Corée du Sud] ; Y. Chwae [Corée du Sud] ; H. Park [Corée du Sud]	Autophagy mechanisms in sputum and peripheral blood cells of patients with severe asthma: a new therapeutic target
000F26 (2015)	Marionna Cathomas [Suisse] ; Alexandra Schüller [Suisse] ; Daniel Candinas [Suisse] ; Roman Inglin [Suisse]	Severe postoperative wound healing disturbance in a patient with alpha‐1‐antitrypsin deficiency: the impact of augmentation therapy
001109 (2013)	S. Walters [Royaume-Uni] ; N. Bhatt ; A R L. Medford	Reversible cerebellar signs due to sarcoid-related severe hypercalcaemia.
001153 (2013)	I. Pérez-Martín ; R. Blanco ; N. Ortego ; V. Llorens-Bellés [Espagne] ; A. Adán [Espagne] ; A. Olivé ; W. A. Sifuentes Giraldo [Espagne] ; S. González [Espagne] ; C. Bejerano ; M. C. González-Vela ; M. A. González-L Pez ; H. Fernández-Llaca ; A. Oterino ; M. J. Sedano ; M. Agudo ; A. Corrales ; V. M. Martínez-Taboada ; M. A. G Nzalez-Gay	THU0391 Anti-TNF therapy in severe and refractory sarcoidosis: Multicenter study of 25 patients
001167 (2013)	Sang Yeob Lee [Corée du Sud] ; Sung Won Lee [Corée du Sud] ; Won Tae Chung [Corée du Sud]	Severe inflammation may be caused by hyperferritinemia of pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review
001224 (2013)		Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study)
001321 (2012)	Estee Chan [Nouvelle-Zélande] ; Fiona Mcqueen [Nouvelle-Zélande]	Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature
001400 (2012)	J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni]	Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients
001437 (2012)	Luke R. G. Pike [Royaume-Uni] ; Kanchan Phadwal [Royaume-Uni] ; Anna Katharina Simon [Royaume-Uni] ; Adrian L. Harris [Royaume-Uni]	ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia
001509 (2011)	Inès Zaraa [Tunisie] ; Meriem Jones [Tunisie] ; Sondes Trojjet [Tunisie] ; Rym Cheikh Rouhou [Tunisie] ; Dalenda El Euch [Tunisie] ; Mourad Mokni [Tunisie] ; Amel Ben Osman [Tunisie]	Severe adverse cutaneous drug eruptions: epidemiological and clinical features

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "severe" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "severe" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    severe
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021